In deliveryUnited KingdomServices£600,000
Next Generation Sequencing Testing (NGS)
- Published
- Published 15 May 2025
- Deadline
- Closed 20 February 2026
Overview
NHS Blood and Transplant procured Next Generation Sequencing (NGS) quality control testing services for the Clinical Biotechnology Centre's production of Advanced Therapeutic Investigational Medicinal Products and starter material master cell banks, meeting specific regulatory requirements. The contract was awarded to SGS United Kingdom Limited on 23 June 2026 for £407,200 and is now in delivery/complete.
Key details
- Country
- United Kingdom
- Status
- In delivery
- Category
- Services
- Estimated value
- £600,000
- Procedure
- Open
- SME suitable
- Yes
- Published
- 15 May 2025
- Questions by
- 13 February 2026
- Deadline
- Closed
System quality assurance assessment and review services
Award outcome
- Awarded value
- £407,200
- Award date
- 23 June 2026
- Contract period
- 31 March 2026 → 31 March 2027
- SGS United Kingdom Limited
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
25 June 2026
View notice ↗Tender Update
26 January 2026
View notice ↗Contract Notice
12 January 2026
View notice ↗Prior Information Notice
15 May 2025
View notice ↗
Contracting authority
NHS Blood and Transplant
BuyerBristol, United Kingdom
GB-PPON: PDBY-6395-VWBP
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.